Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Inhibitor-based deep mutational scanning of MET kinase

PROVIDER: PRJNA1136906 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29860900_1.fastq.gz	Fastqsanger.gz
	SRR29860900_2.fastq.gz	Fastqsanger.gz
	SRR29861000_1.fastq.gz	Fastqsanger.gz
	SRR29861000_2.fastq.gz	Fastqsanger.gz
	SRR29861100_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 440

Similar Datasets

Project description:Deep mutational scanning of Met kinase

| PRJNA993160 | ENA

Project description:SHP2 deep mutational scanning

| PRJNA1232161 | ENA

Project description:Deep mutational scanning of hOCT1

| PRJNA980726 | ENA

Project description:VIM-2 deep mutational scanning

| PRJNA606894 | ENA

Project description:Rad54 deep mutational scanning data

| PRJNA1235687 | ENA

Project description:Deep Mutational Scanning NJ-RBM

| PRJNA1237868 | ENA

A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins

Project description:Deep mutational scanning is a powerful method for exploring the mutational fitness landscape of proteins. Its adaptation to anti-CRISPR proteins, which are natural CRISPR-Cas inhibitors and key players in the co-evolution of microbes and phages, facilitates their characterization and optimization. Here, we developed a robust anti-CRISPR deep mutational scanning pipeline in Escherichia coli that combines synthetic gene circuits based on CRISPR interference with flow cytometry coupled sequencing and mathematical modeling. Using this pipeline, we characterized comprehensive single point mutation libraries for AcrIIA4 and AcrIIA5, two potent inhibitors of CRISPR-Cas9. The resulting mutational fitness landscapes revealed considerable mutational tolerance for both Acrs, suggesting an intrinsic redundancy with respect to Cas9 inhibitory features, and – for AcrIIA5 – indicated mutations that boost Cas9 inhibition. Subsequent in vitro characterization suggested that the observed differences in inhibitory potency between mutant inhibitors were mostly due to changes in binding affinity rather than protein expression levels. Finally, to demonstrate that our pipeline can inform Acrs-based genome editing applications, we employed a selected subset of mutant inhibitors to increase CRISPR-Cas9 target specificity by modulating Cas9 activity. Taken together, our work establishes deep mutational scanning as a powerful method for anti-CRISPR protein characterization and optimization.

2024-03-01 | GSE254101 | GEO

Escherichia coli strain:ER2566

Project description:E. Coli DHFR Deep Mutational Scanning

| PRJNA590072 | ENA

Project description:Type-1 myosin deep mutational scanning

| PRJNA1079703 | ENA

Project description:Deep mutational scanning of CPEB3 ribozyme

| PRJNA515794 | ENA